Paper · 45919

Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome).

Creutzfeldt W and 3 others. Hum Pathol, 1975. Cited by 214 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome). Papers, record 45919. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/45919

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome).; PubMed
Journal: Hum Pathol; PubMed
Year: 1975; PubMed
Publication types: Journal Article; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/45919/; PubMed
DOI: https://doi.org/10.1016/s0046-8177(75)80109-2; PubMed
The journal: https://conductscience.org/library/journal-index/9421547; PubMed
Citations, by iCite: 214; iCite
Relative citation ratio, by iCite: 9.36; iCite
Revised in PubMed: 2019-07-22; PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Creutzfeldt W	W
2	Arnold R	R
3	Creutzfeldt C	C
4	Track NS	N S

Source PubMed

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Zollinger-Ellison Syndrome	Major topic
Antigens, Neoplasm
Calcium
Chromatography, Gel
Duodenal Neoplasms
Eating
Gastrins
Glucagon
Humans
Immune Sera
Insulin
Intestinal Mucosa
Islets of Langerhans
Lymphatic Metastasis
Microscopy, Electron
Neoplasm Metastasis
Pancreatic Neoplasms
Radioimmunoassay
Secretin
Staining and Labeling

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

Trial	Title	The trial lists it as	Named in the paper's record
NCT00001254	Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome	Background

Source ClinicalTrials.gov

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 214 citations.

PMID	Title	Journal	Year	In Papers	Source
37,371,827	Diffuse, Adult-Onset Nesidioblastosis/Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS): Review of the Literature of a Rare Cause of Hyperinsulinemic Hypoglycemia.	Biomedicines	2023	https://conductscience.org/library/papers/37371827	PubMed
36,900,170	Successful Lifetime/Long-Term Medical Treatment of Acid Hypersecretion in Zollinger-Ellison Syndrome (ZES): Myth or Fact? Insights from an Analysis of Results of NIH Long-Term Prospective Studies of ZES.	Cancers (Basel)	2023	https://conductscience.org/library/papers/36900170	PubMed
32,138,398	Gut endocrine and neural peptides.	Endocr Pathol	1990	https://conductscience.org/library/papers/32138398	PubMed
27,408,649	Zollinger-Ellison syndrome: Revelation of the gastrinoma triangle.	Radiol Case Rep	2015	https://conductscience.org/library/papers/27408649	PubMed
18,679,689	Giant gastrinoma in a child: case report and review.	Pediatr Surg Int	2008	https://conductscience.org/library/papers/18679689	PubMed
17,108,779	Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.	Medicine (Baltimore)	2006	https://conductscience.org/library/papers/17108779	PubMed
17,108,778	Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.	Medicine (Baltimore)	2006	https://conductscience.org/library/papers/17108778	PubMed
17,016,695	Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humans.	Diabetologia	2006	https://conductscience.org/library/papers/17016695	PubMed
16,926,567	Surgery increases survival in patients with gastrinoma.	Ann Surg	2006	https://conductscience.org/library/papers/16926567	PubMed
15,688,179	[Zollinger-Ellison syndrome].	Chirurg	2005	https://conductscience.org/library/papers/15688179	PubMed

1 to 10 of 46

See all 46 cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
GAST	2,520	PubTator's text mining	https://conductscience.org/library/genes/2520	NCBI Gene
GCG	2,641	PubTator's text mining	https://conductscience.org/library/genes/2641	NCBI Gene
SCT	6,343	PubTator's text mining	https://conductscience.org/library/genes/6343	NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/45919

GET https://conductscience.org/api/papers/v1/45919/cited_by?page=2

API reference For AI assistants